Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume

Journal of the American Society of Echocardiography

Volumn 29, Issue 4, 2016, Pages 359-367

  Kadappu, Krishna K ^a,b,c,d   Abhayaratna, Katrina ^e   Boyd, Anita ^f   French, John K ^a,b   Xuan, Wei ^a,g   Abhayaratna, Walter ^e   Thomas, Liza ^a,b,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c CAMPBELLTOWN HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

^e CANBERRA HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

Author keywords

Chronic kidney disease; Left atrial strain; Left atrial volume; Left atrium; Left ventricular strain

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FUNCTION; HEART LEFT ATRIUM; HEART LEFT ATRIUM FUNCTION; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEART VOLUME; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TRANSTHORACIC ECHOCARDIOGRAPHY; COMPLICATION; DIAGNOSTIC IMAGING; DISEASE COURSE; ETIOLOGY; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC;

AGED; ATRIAL FUNCTION, LEFT; CARDIAC VOLUME; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84960843412     PISSN: 08947317     EISSN: 10976795     Source Type: Journal    
DOI: 10.1016/j.echo.2015.11.019     Document Type: Article

References (40)

1. 1 Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E., Hsu, C.Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004), 1296–1305.
2. 2 Foley, R.N., Parfrey, P.S., Sarnak, M.J., Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9 (1998), S16–S23.
3. 3 Weiner, D.E., Tighiouart, H., Elsayed, E.F., Griffith, J.L., Salem, D.N., Levey, A.S., et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 50 (2007), 217–224.
4. 4 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002), S1–266.
5. 5 Levey, A.S., Eckardt, K.U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005), 2089–2100.
6. 6 Foley, R.N., Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 16 (2003), 111–117.
7. 7 Liu, Y.W., Su, C.T., Huang, Y.Y., Yang, C.S., Huang, J.W., Yang, M.T., et al. Left ventricular systolic strain in chronic kidney disease and hemodialysis patients. Am J Nephrol 33 (2011), 84–90.
8. 8 Yan, P., Li, H., Hao, C., Shi, H., Gu, Y., Huang, G., et al. 2D-speckle tracking echocardiography contributes to early identification of impaired left ventricular myocardial function in patients with chronic kidney disease. Nephron Clin Pract 118 (2011), c232–c240.
9. 9 Tripepi, G., Benedetto, F.A., Mallamaci, F., Tripepi, R., Malatino, L., Zoccali, C., Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 18 (2007), 1316–1322.
10. 10 Ehrlich, J.R., Hohnloser, S.H., Nattel, S., Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 27 (2006), 512–518.
11. 11 Saito, M., Okayama, H., Yoshii, T., Higashi, H., Morioka, H., Hiasa, G., et al. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 13 (2012), 617–623.
12. 12 Vianna-Pinton, R., Moreno, C.A., Baxter, C.M., Lee, K.S., Tsang, T.S., Appleton, C.P., Two-dimensional speckle-tracking echocardiography of the left atrium: feasibility and regional contraction and relaxation differences in normal subjects. J Am Soc Echocardiogr 22 (2009), 299–305.
13. 13 Sarnak, M.J., Levey, A.S., Schoolwerth, A.C., Coresh, J., Culleton, B., Hamm, L.L., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003), 2154–2169.
14. 14 Lang, R.M., Badano, L.P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (2015), 1–39.
15. 15 Foppa, M., Duncan, B.B., Rohde, L.E., Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?. Cardiovasc Ultrasound, 3, 2005, 17.
16. 16 Appleton, C.P., Jensen, J.L., Hatle, L.K., Oh, J.K., Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining optimal flow velocity recordings. J Am Soc Echocardiogr 10 (1997), 271–292.
17. 17 Ommen, S.R., Nishimura, R.A., Appleton, C.P., Miller, F.A., Oh, J.K., Redfield, M.M., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102 (2000), 1788–1794.
18. 18 Nagueh, S.F., Appleton, C.P., Gillebert, T.C., Marino, P.N., Oh, J.K., Smiseth, O.A., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22 (2009), 107–133.
19. 19 Kadappu, K.K., Boyd, A., Eshoo, S., Haluska, B., Yeo, A.E., Marwick, T.H., et al. Changes in left atrial volume in diabetes mellitus: more than diastolic dysfunction?. Eur Heart J Cardiovasc Imaging 13 (2012), 1016–1023.
20. 20 Agoston, G., Gargani, L., Miglioranza, M.H., Caputo, M., Badano, L.P., Moreo, A., et al. Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. Cardiovasc Ultrasound, 12, 2014, 30.
21. 21 Hoit, B.D., Left atrial size and function: role in prognosis. J Am Coll Cardiol 63 (2014), 493–505.
22. 22 Cameli, M., Caputo, M., Mondillo, S., Ballo, P., Palmerini, E., Lisi, M., et al. Feasibility and reference values of left atrial longitudinal strain imaging by two-dimensional speckle tracking. Cardiovasc Ultrasound, 7, 2009, 6.
23. 23 Morris, D.A., Takeuchi, M., Krisper, M., Kohncke, C., Bekfani, T., Carstensen, T., et al. Normal values and clinical relevance of left atrial myocardial function analysed by speckle-tracking echocardiography: multicentre study. Eur Heart J Cardiovasc Imaging 16 (2015), 364–372.
24. 24 Grundy, S.M., Balady, G.J., Criqui, M.H., Fletcher, G., Greenland, P., Hiratzka, L.F., et al. Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. Circulation 95 (1997), 2329–2331.
25. 25 Foley, R.N., Parfrey, P.S., Harnett, J.D., Kent, G.M., Martin, C.J., Murray, D.C., et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47 (1995), 186–192.
26. 26 Levin, A., Singer, J., Thompson, C.R., Ross, H., Lewis, M., Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 27 (1996), 347–354.
27. 27 McIntyre, C.W., John, S.G., Jefferies, H.J., Advances in the cardiovascular assessment of patients with chronic kidney disease. NDT Plus 6 (2008), 383–391.
28. 28 Shizuku, J., Yamashita, T., Ohba, T., Kabaya, T., Nitta, K., Left atrial volume is an independent predictor of all-cause mortality in chronic hemodialysis patients. Intern Med 51 (2012), 1479–1485.
29. 29 Tripepi, G., Benedetto, F.A., Mallamaci, F., Tripepi, R., Malatino, L., Zoccali, C., Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens 24 (2006), 1173–1180.
30. 30 Tripepi, G., Mattace-Raso, F., Mallamaci, F., Benedetto, F.A., Witteman, J., Malatino, L., et al. Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. Hypertension 54 (2009), 818–824.
31. 31 Moller, J.E., Hillis, G.S., Oh, J.K., Seward, J.B., Reeder, G.S., Wright, R.S., et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 107 (2003), 2207–2212.
32. 32 Kadappu, K.K., Kuncoro, A.S., Hee, L., Aravindan, A., Spicer, S.T., Suryanarayanan, G., et al. Chronic kidney disease is independently associated with alterations in left atrial function. Echocardiography 31 (2014), 956–964.
33. 33 Chen, S.C., Su, H.M., Hung, C.C., Chang, J.M., Liu, W.C., Tsai, J.C., et al. Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol 6 (2011), 2750–2758.
34. 34 Edwards, N.C., Hirth, A., Ferro, C.J., Townend, J.N., Steeds, R.P., Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy?. J Am Soc Echocardiogr 21 (2008), 1293–1298.
35. 35 Krishnasamy, R., Isbel, N.M., Hawley, C.M., Pascoe, E.M., Leano, R., Haluska, B.A., et al. The association between left ventricular global longitudinal strain, renal impairment and all-cause mortality. Nephrol Dial Transplant 29 (2014), 1218–1225.
36. 36 Ng, A.C., Delgado, V., Bertini, M., van der Meer, R.W., Rijzewijk, L.J., Shanks, M., et al. Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 104 (2009), 1398–1401.
37. 37 Cameli, M., Lisi, M., Focardi, M., Reccia, R., Natali, B.M., Sparla, S., et al. Left atrial deformation analysis by speckle tracking echocardiography for prediction of cardiovascular outcomes. Am J Cardiol 110 (2012), 264–269.
38. 38 Shaikh, A.Y., Maan, A., Khan, U.A., Aurigemma, G.P., Hill, J.C., Kane, J.L., et al. Speckle echocardiographic left atrial strain and stiffness index as predictors of maintenance of sinus rhythm after cardioversion for atrial fibrillation: a prospective study. Cardiovasc Ultrasound, 10, 2012, 48.
39. 39 Dimitroula, H., Damvopoulou, E., Giannakoulas, G., Dalamanga, E., Dimitroulas, T., Sarafidis, P.A., et al. Effects of renin-angiotensin system inhibition on left atrial function of hypertensive patients: an echocardiographic tissue deformation imaging study. Am J Hypertens 23 (2010), 556–561.
40. 40 Kokubu, N., Yuda, S., Tsuchihashi, K., Hashimoto, A., Nakata, T., Miura, T., et al. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of renin-angiotensin system inhibition on left atrial function. Hypertens Res 30 (2007), 13–21.